TREDER Martin,REUSCH Uwe,MARSCHNER Jens-Peter,KNACKMUSS Stefan
申请号:
SI201630463
公开号:
SI3292153T1
申请日:
2016.05.04
申请国别(地区):
SI
年份:
2020
代理人:
摘要:
Described is a combination therapy of (i) a multifunctional antibody having specificity for CD30 and CD16A and (ii) an anti-PD-1 antibody for the treatment of a tumor, in particular Hodgkin lymphoma.